News

What is the difference between Type 1 and Type 2 diabetes? What about pre-diabetes? And how does insulin resistance factor in? Here's what to know.
Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...
In a US Phase I and II clinical trial evaluating another FcR-nonbinding anti-CD3 antibody (teplizumab or hOKT3γ1 Ala–Ala) at the time of onset of Type 1 diabetes, anti-CD3 treatment halted the ...
Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to ...